scholarly journals Effectiveness of a financial incentive to physicians for timely follow-up after hospital discharge: a population-based time series analysis

2017 ◽  
Vol 189 (39) ◽  
pp. E1224-E1229 ◽  
Author(s):  
Lauren Lapointe-Shaw ◽  
Muhammad Mamdani ◽  
Jin Luo ◽  
Peter C. Austin ◽  
Noah M. Ivers ◽  
...  
2021 ◽  
Vol 41 (2) ◽  
pp. 57-64
Author(s):  
Andrew Appleton ◽  
Melody Lam ◽  
Britney Le ◽  
Salimah Shariff ◽  
Andrea Gershon

Introduction Physician payment models are known to affect the nature and volume of services provided. Our objective was to study the effects of removing a financial incentive, the fee-for-service premium, on the provision of chronic disease follow-up services by internal medicine, cardiology, nephrology and gastroenterology specialists. Methods We collected linked administrative health care data for the period 1 April 2013 to 31 March 2017 from databases held at the Institute for Clinical Evaluative Sciences (ICES) in Ontario, Canada. We conducted a time-series analysis before and after the removal of the fee-for-service premium on 1 April 2015. The primary outcome was total monthly visits for chronic disease follow-up services. Secondary outcomes were monthly visits for total follow-up services and new patient consultations. We compared internal medicine, cardiology, nephrology and gastroenterology specialists practising during the study timeframe with respirology, hematology, endocrinology, rheumatology and infectious diseases specialists who remained eligible to claim the premium. We chose this comparison group as these are all subspecialties of internal medicine, providing similar services. Results The number of chronic disease follow-up visits decreased significantly after removal of the premium, but there was no decrease in total follow-up visits. There was also a significant downward trend in new patient consultations. No changes were observed in the comparison group. Conclusion The decrease in volume of chronic disease follow-up visits can be explained by diagnostic criteria being met less often, rather than an actual reduction in services provided. Potential effects on patient outcomes require further exploration.


Addiction ◽  
2021 ◽  
Author(s):  
Tony Antoniou ◽  
Diana Martins ◽  
Tonya Campbell ◽  
Mina Tadrous ◽  
Charlotte Munro ◽  
...  

2014 ◽  
Vol 192 (5) ◽  
pp. 1450-1456 ◽  
Author(s):  
Michael Ordon ◽  
David Urbach ◽  
Muhammad Mamdani ◽  
Refik Saskin ◽  
R. John D’A Honey ◽  
...  

1995 ◽  
Vol 222 (3) ◽  
pp. 311-326 ◽  
Author(s):  
Robert Rutledge ◽  
John P. Hunt ◽  
Christopher W. Lentz ◽  
Samir M. Fakhry ◽  
Anthony A. Meyer ◽  
...  

Author(s):  
Ippazio Cosimo Antonazzo ◽  
Carla Fornari ◽  
Sandy Maumus-Robert ◽  
Eleonora Cei ◽  
Olga Paoletti ◽  
...  

Background: In 2020, during the COVID-19 pandemic, Italy implemented two national lockdowns aimed at reducing virus transmission. We assessed whether these lockdowns affected anti-seizure medication (ASM) use and epilepsy-related access to emergency departments (ED) in the general population. Methods: We performed a population-based study using the healthcare administrative database of Tuscany. We defined the weekly time series of prevalence and incidence of ASM, along with the incidence of epilepsy-related ED access from 1 January 2018 to 27 December 2020 in the general population. An interrupted time-series analysis was used to assess the effect of lockdowns on the observed outcomes. Results: Compared to pre-lockdown, we observed a relevant reduction of ASM incidence (0.65; 95% Confidence Intervals: 0.59–0.72) and ED access (0.72; 0.64–0.82), and a slight decrease of ASM prevalence (0.95; 0.94–0.96). During the post-lockdown the ASM incidence reported higher values compared to pre-lockdown, whereas ASM prevalence and ED access remained lower. Results also indicate a lower impact of the second lockdown for both ASM prevalence (0.97; 0.96–0.98) and incidence (0.89; 0.80–0.99). Conclusion: The lockdowns implemented during the COVID-19 outbreaks significantly affected ASM use and epilepsy-related ED access. The potential consequences of these phenomenon are still unknown, although an increased incidence of epilepsy-related symptoms after the first lockdown has been observed. These findings emphasize the need of ensuring continuous care of epileptic patients in stressful conditions such as the COVID-19 pandemic.


2017 ◽  
Vol 108 (5-6) ◽  
pp. e462-e467 ◽  
Author(s):  
Naveen Poonai ◽  
Shruti Mehrotra ◽  
Muhammad Mamdani ◽  
Anastasia Patmanidis ◽  
Michael Miller ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document